Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population
Julia Kozlitina, Sonia Garg, Mark H. Drazner, Susan A. Matulevicius, Colby Ayers, John D. Overton, Jeffrey G. Reid, Aris Baras, Krishnasree Rao, Ambarish Pandey, Jarett D. Berry, James A. de Lemos, Justin L. Grodin
Topics & Concepts
Interquartile rangeHazard ratioMedicineTransthyretinInternal medicineConfidence intervalCardiac magnetic resonance imagingCardiologyHeart failurePopulationMagnetic resonance imagingGastroenterologyRadiologyEnvironmental healthAmyloidosis: Diagnosis, Treatment, OutcomesParathyroid Disorders and TreatmentsAlzheimer's disease research and treatments